Qidantongmai Tablet, and its preparing process

Abstract

The present invention provides a Chinese medicine Qidan Tongmai tablet for effectively curing the diseases of coronary heart disease and angina pectoris, etc. It is made up by using 5 Chinese medicinal materials of astragalus root, salvia root and others through a certain preparation process. Said invention also provides the concrete steps of said preparation method.

Description

Technical field [0001] The Qidan Tongmai Tablet and its preparation process of the invention belong to the pure traditional Chinese medicine preparation for treating internal diseases and its production and processing method, in particular to an oral medicine for treating thoracic obstruction (angina pectoris due to coronary heart disease) and its preparation process. Background technique [0002] Chest obstruction (angina pectoris due to coronary heart disease) is a common critical illness among middle-aged and elderly people with high morbidity and mortality. Internal pain, shortness of breath, palpitations, spontaneous sweating, and angina pectoris are the most common symptoms, mostly caused by blockage of heart yang, deficiency of heart yang, blockage of heart vessels, and poor circulation of qi and blood. The risk factor is hyperlipidemia syndrome, high blood pressure, diabetes, smoking and bad eating habits, there are many kinds of Chinese patent medicines for the trad...

AI Technical Summary

Problems solved by technology

[0002] Chest obstruction (angina pectoris due to coronary heart disease) is a common critical illness among middle-aged and elderly people with high morbidity and mortality. Internal pain, shortness of breath, palpitations, spontaneous sweating, and angina pectoris are the most common symptoms, mostly caused by blockage of heart yang, deficiency of heart yang, blockage of heart vessels, and poor circulation of qi and blood. The risk factor is hyperlipidemia syndrome, high blood pressure, diabetes, smoking and bad eating habits, there are many kinds of Chinese patent medicines for the traditional treatment of thoracic obstruction (angina pectoris of coronary heart disease). Numbness resistance or heart yang deficiency caused by different syndromes of deficiency in origin, superficiality in superficiality, and interlacing of deficiency and excess. In the development of new drugs, pharmacodynamic experiments mostly ignore the relationship between heart pump and blood internal elasticity, heart function and the formation of cardiovascular microthrombosis. According to multi-level experiments, the curative effect of many new drugs for the treatment of thoracic obstruction (coronary heart disease angina pectoris) is not satisfactory. With the continuous improvement of people's living standards, the population of patients with hyperlipidemia, hypertension, and diabetes continues to increase, and the population of thoracic obstruction is also increasing. , the development of effective, safe and reliable new drugs for the treatment of thoracic obstruction (angina pectoris of coronary heart disease), heart-qi deficiency, blood stasis and arterial obstruction has a broad application market